The 2016 Lasker-DeBakey Clinical Medical Research Award: Innovative hepatitis C virus (HCV) replicons leading to drug development for hepatitis C cure
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-1889
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The 2016 Lasker-DeBakey Clinical Medical Research Award: Innovative hepatitis C virus (HCV) replicons leading to drug development for hepatitis C cure ; volume:59 ; number:11 ; day:26 ; month:10 ; year:2016 ; pages:1198-1201 ; date:11.2016
Science China / Life sciences. Life sciences ; 59, Heft 11 (26.10.2016), 1198-1201, 11.2016
- Creator
-
Zhao, Qinjian
- Contributor
-
Xia, Ningshao
SpringerLink (Online service)
- DOI
-
10.1007/s11427-016-0313-9
- URN
-
urn:nbn:de:1111-2016120117377
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhao, Qinjian
- Xia, Ningshao
- SpringerLink (Online service)
Other Objects (12)
New Hepatitis C Virus (HCV) Drugs and the Hope for a Cure: Concepts in Anti-HCV Drug Development
From non-A, non-B hepatitis to hepatitis C virus cure
HCV Seroreactivity and Detection of HCV RNA in Hepatitis Cases
Tickling the TLR7 to cure viral hepatitis
HCV cure without interferon
Hepatitis C: milestones from discovery to clinical cure
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Hepatitis B vaccine efficacy in HCV vertical infected infants
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals
Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia
Heterolog rekombinantes Hepatitis-C-Vacciniamodell zur Evaluierung von HCV-Impfstoffen
New Hepatitis C Virus (HCV) Drugs and the Hope for a Cure: Concepts in Anti-HCV Drug Development
From non-A, non-B hepatitis to hepatitis C virus cure
HCV Seroreactivity and Detection of HCV RNA in Hepatitis Cases
Tickling the TLR7 to cure viral hepatitis
HCV cure without interferon
Hepatitis C: milestones from discovery to clinical cure
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Hepatitis B vaccine efficacy in HCV vertical infected infants
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals
Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia
Heterolog rekombinantes Hepatitis-C-Vacciniamodell zur Evaluierung von HCV-Impfstoffen
New Hepatitis C Virus (HCV) Drugs and the Hope for a Cure: Concepts in Anti-HCV Drug Development
From non-A, non-B hepatitis to hepatitis C virus cure
HCV Seroreactivity and Detection of HCV RNA in Hepatitis Cases
Tickling the TLR7 to cure viral hepatitis
HCV cure without interferon
Hepatitis C: milestones from discovery to clinical cure
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Hepatitis B vaccine efficacy in HCV vertical infected infants
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals
Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia